Pharma & Biotech
Pressure BioSciences eyes strong revenue from three blockbuster pressure-based technology platforms
Security Devices hits the bullseye with the Byrna, which is targeted at the non-lethal weapons market
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.